Clinical Trial Update: Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating prostaglandin E1 (Liprostin) in combination with lower limb angioplasty for peripheral arterial occlusive disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease
• Peripheral Vascular Disease

Drugs mentioned

• Liprostin (Prostaglandin E1)

Snippet

Sponsor: Endovasc | Conditions: Peripheral Vascular Disease | Phase 2 | Status: UNKNOWN